Loading...

ZVSA ZYVERSA THERAPEUTICS INC Management Changes 8-K Filing

ZYVR

ZVS

ZYVERSA THERAPEUTICS INC

(ZVSA)

2023 8-K

Show Summary

Summary

Forced Delisting

Warrant Inducement

Equity Offerings

Management Changes

Forced Delisting

Accountant Change

Private Placement

Quarterly Results

Warrant Inducement

Annual Meeting Results

Warrant Exercise Inducement...

Reverse Stock Split

Special Meeting Approval

Dismissal of Independent Re...

Securities Purchase Agreement

Reverse Stock Split and Aut...

Annual Meeting of Stockholders

Warrant Exercise Inducement...

Retirement and Stockholder ...

Public Offering and Private...

Delisting Notice

Financial Results

Financial Disclosure

Court Petition for Validati...

Agreement with L&F Research...

Appointment of Directors

External Links:

ZyVersa Therapeutics announces retirement of Chief Scientific Officer and Senior Vice President of Research and Development, Nicholas A. LaBella, Jr., and sets deadline for stockholder proposals for 2023 Annual Meeting.

AI Assistant

ZYVERSA THERAPEUTICS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.